Thorsten Berg
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Thorsten Berg has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
Wolfgang Reindl
Department of Molecular Biology, Max Planck Institute of Biochemistry, Center for Integrated Protein Science Munich, Am Klopferspitz 18, 82152 Martinsried, Germany
3 shared publicationsAndrea Krämer
Johann Wolfgang Goethe-University, Medical School, Department of Gynecology and Obstetrics, Theodor-Stern-Kai 7-9, 60596 Frankfurt (Germany), Fax: (+49) 69-6301-6364
2 shared publicationsAnke Kiessling
Max Planck Institute of Biochemistry, Department of Molecular Biology, Am Klopferspitz 18, 82152 Martinsried, Germany, and Munich Center for Integrated Protein Science (CiPSM), Fax: (+49) 89-8578-2454
2 shared publicationsBianca Sperl
Max Planck Institute of Biochemistry, Department of Molecular Biology, Am Klopferspitz 18, 82152 Martinsried, Germany, and Munich Center for Integrated Protein Science (CiPSM), Fax: (+49) 89-8578-2454
2 shared publications- Klaus Strebhardt
Department of Gynecology, Medical School, Goethe-University, 60596 Frankfurt am Main, Germany
2 shared publications Beatrix Süß
Universität Erlangen‐Nürnberg
1 shared publication
Latest Publications
- 1 May 2010
- Published by World Scientific Pub Co Pte Ltd
- Vol. 11 (5) , 318-339
Small-Molecule Inhibitors of Protein–Protein Interactions
The majority of current FDA-approved small molecules target enzymes and cell surface receptors. While there is no doubt that these protein classes are excellent drug targets, it is also well-known that they constitute only a minor proportion of all human proteins. Therefore, the development of approaches that allow for the expansion of the number of protein classes that can be targeted by small molecules is a major challenge to academic research. Because most biological processes are performed by protein complexes and the function of a protein can depend on its binding partners, the inhibition of protein–protein interactions bears tremendous potential to render additional protein families accessible to functional modulation by small molecules. This chapter highlights the case stories of selected inhibitors of protein–protein interactions which illustrate the current scope of the field.
- 1 May 2010
- Published by World Scientific Pub Co Pte Ltd
- Vol. 11 (5) , 318-339
Small-Molecule Inhibitors of Protein–Protein Interactions
The majority of current FDA-approved small molecules target enzymes and cell surface receptors. While there is no doubt that these protein classes are excellent drug targets, it is also well-known that they constitute only a minor proportion of all human proteins. Therefore, the development of approaches that allow for the expansion of the number of protein classes that can be targeted by small molecules is a major challenge to academic research. Because most biological processes are performed by protein complexes and the function of a protein can depend on its binding partners, the inhibition of protein–protein interactions bears tremendous potential to render additional protein families accessible to functional modulation by small molecules. This chapter highlights the case stories of selected inhibitors of protein–protein interactions which illustrate the current scope of the field.
- 25 April 2009
- Published by Wiley in ChemBioChem
- Vol. 10 (7) , 1145-1148
A Pan‐Specific Inhibitor of the Polo‐Box Domains of Polo‐like Kinases Arrests Cancer Cells in Mitosis
Playing polo: Small‐molecule inhibitors of polo‐like kinase 1 are mostly ATP‐competitive, and thus face enormous specificity hurdles. This communication explores the concept of inhibiting Plk1 with a small‐molecule inhibitor of the protein–protein interactions required for Plk1 function. magnified image
- 25 April 2009
- Published by Wiley in ChemBioChem
- Vol. 10 (7) , 1145-1148
A Pan‐Specific Inhibitor of the Polo‐Box Domains of Polo‐like Kinases Arrests Cancer Cells in Mitosis
Playing polo: Small‐molecule inhibitors of polo‐like kinase 1 are mostly ATP‐competitive, and thus face enormous specificity hurdles. This communication explores the concept of inhibiting Plk1 with a small‐molecule inhibitor of the protein–protein interactions required for Plk1 function. magnified image
- Open Access
- 25 April 2009
- Published by Wiley in ChemBioChem
- Vol. 10 (7) , 1109
Cover Picture: A Pan‐Specific Inhibitor of the Polo‐Box Domains of Polo‐like Kinases Arrests Cancer Cells in Mitosis (ChemBioChem 7/2009)
- 25 April 2009
- Published by Wiley in ChemBioChem
- Vol. 10 (7) , 1109
Open AccessCover Picture: A Pan‐Specific Inhibitor of the Polo‐Box Domains of Polo‐like Kinases Arrests Cancer Cells in Mitosis (ChemBioChem 7/2009)
- 15 April 2009
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 48 (18) , 3218-3220
Allosteric Switches: Remote Controls for Proteins
Long‐distance service: Finding a selective small‐molecule modulator for every domain of every human protein is a Herculean task. Wouldn't it be much easier to control the activity of any protein of choice by simply fusing it with a generally adaptable switch protein and controlling protein activity indirectly? magnified image
- 15 April 2009
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 48 (18) , 3218-3220
Allosteric Switches: Remote Controls for Proteins
Long‐distance service: Finding a selective small‐molecule modulator for every domain of every human protein is a Herculean task. Wouldn't it be much easier to control the activity of any protein of choice by simply fusing it with a generally adaptable switch protein and controlling protein activity indirectly? magnified image
- 15 April 2009
- Published by Wiley in Angewandte Chemie
- Vol. 121 (18) , 3265-3267
Allosterische Schalter: Fernsteuerungen für Proteine
- 15 April 2009
- Published by Wiley in Angewandte Chemie
- Vol. 121 (18) , 3265-3267
Allosterische Schalter: Fernsteuerungen für Proteine
- 27 August 2008
- Published by Wiley in ChemBioChem
- Vol. 9 (13) , 2039-2044
Signal Transducers and Activators of Transcription as Targets for Small Organic Molecules
Signal transducers and activators of transcription (STATs) are a family of transcription factors that are of central importance for cellular signaling and have therefore emerged as attractive target proteins for cell‐permeable small molecules. This review outlines the basic concept of STAT signaling, the relevance of individual members of the STAT family for cellular signaling and human disease, and generally applicable approaches taken to the identification of small‐molecule inhibitors of STATs.
- 27 August 2008
- Published by Wiley in ChemBioChem
- Vol. 9 (13) , 2039-2044
Signal Transducers and Activators of Transcription as Targets for Small Organic Molecules
Signal transducers and activators of transcription (STATs) are a family of transcription factors that are of central importance for cellular signaling and have therefore emerged as attractive target proteins for cell‐permeable small molecules. This review outlines the basic concept of STAT signaling, the relevance of individual members of the STAT family for cellular signaling and human disease, and generally applicable approaches taken to the identification of small‐molecule inhibitors of STATs.
- 1 August 2008
- Published by Elsevier in Current Opinion in Chemical Biology
- Vol. 12 (4) , 464-471
Inhibition of transcription factors with small organic molecules
- 1 August 2008
- Published by Elsevier in Current Opinion in Chemical Biology
- Vol. 12 (4) , 464-471
Inhibition of transcription factors with small organic molecules
- 14 March 2008
- Published by Wiley in ChemBioChem
- Vol. 9 (5) , 723-727
Discovery of Chromone‐Based Inhibitors of the Transcription Factor STAT5
- 14 March 2008
- Published by Wiley in ChemBioChem
- Vol. 9 (5) , 723-727
Discovery of Chromone‐Based Inhibitors of the Transcription Factor STAT5
- 30 April 2007
- Published by Wiley in ChemMedChem
- Vol. 2 (5) , 627-630
Selective Inhibition of c‐Myc/Max Dimerization by a Pyrazolo[1,5‐a]pyrimidine
- 30 April 2007
- Published by Wiley in ChemMedChem
- Vol. 2 (5) , 627-630
Selective Inhibition of c‐Myc/Max Dimerization by a Pyrazolo[1,5‐a]pyrimidine
- 30 June 2006
- Published by Wiley in ChemMedChem
- Vol. 1 (7) , 687-688
Inhibition of TNF‐α Signaling: Divide and Conquer
- 30 June 2006
- Published by Wiley in ChemMedChem
- Vol. 1 (7) , 687-688
Inhibition of TNF‐α Signaling: Divide and Conquer